INSTRUCTIONAL COURSE EVALUATION

IC 6: Integrated Management Using Botulinum Toxin A for Upper Extremity Hypertonia in Children with Cerebral Palsy
Mauricio Delgado, MD; Nigar Dursun, MD; Angela Shierk, OTR, PhD

Learning Objective:
1) To understand the level of evidence for the use of BoNT-A in upper extremity spasticity in children with CP.
2) To delineate the complexity of the process with highly variable treatment response among patients, and the importance of optimal BoNT-A treatment strategy with multilevel combined treatment approaches.
3) To develop skills and knowledge in making clinical desicions on who to treat, how to treat and follow-up.
4) To discuss safety issues.

Question Title

* 1. Please indicate your opinion about each of the following statements.

  Strongly Agree Agree Neutral Disagree Strongly Disagree
The course followed description in the program.
The course began on time and was well paced.
The faculty communicated clearly and effectively.
The course used practical examples to teach points.
The faculty involved participants in the course.
The faculty allowed enough time for questions.
The course met its objectives as stated in the program.
The information presented will help me accomplish my professional responsibilities.
The course has given me a basis for making changes in my practice.

Question Title

* 2. Did this course have a commercial bias?

Question Title

* 3. Should the Academy repeat this course next year?

Question Title

* 4. Please suggest any topics of interest for a future course.

Question Title

* 5. General comments:

Thank you for taking the time to complete this evaluation. 
Your feedback is valued and greatly appreciated.
( Privacy & Cookie Notice

T